Acadian Asset Management
VIVO

Acadian Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Acadian Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,162
Closed -$92K – 2110
2021
Q2 		$92K Buy
4,162
+60
+1% +$1.27K ﹤0.01% 1651
2021
Q1 		$108K Sell
4,102
-191,484
-98% -$4.55M ﹤0.01% 1658
2020
Q4 		$3.66M Sell
195,586
-229,930
-54% -$4.29M 0.01% 589
2020
Q3 		$7.22M Sell
425,516
-160,435
-27% -$3.12M 0.03% 366
2020
Q2 		$13.6M Sell
585,951
-86,465
-13% -$1.25M 0.06% 276
2020
Q1 		$5.64M Buy
672,416
+57,882
+9% +$487K 0.03% 371
2019
Q4 		$6M Buy
614,534
+186,802
+44% +$1.75M 0.03% 401
2019
Q3 		$4.06M Buy
427,732
+107,423
+34% +$1.13M 0.02% 509
2019
Q2 		$3.8M Buy
320,309
+230,299
+256% +$2.77M 0.02% 452
2019
Q1 		$1.58M Buy
90,010
+25,496
+40% +$424K 0.01% 747
2018
Q4 		$1.12M Buy
+64,514
New +$1.1M 0.01% 709
2018
Q2 		– Sell
-14,147
Closed -$201K – 1893
2018
Q1 		$201K Buy
+14,147
New +$209K ﹤0.01% 1060
2016
Q4 		– Sell
-116,558
Closed -$2.25M – 1809
2016
Q3 		$2.25M Sell
116,558
-459,449
-80% -$8.99M 0.01% 517
2016
Q2 		$11.2M Sell
576,007
-75,617
-12% -$1.48M 0.06% 251
2016
Q1 		$13.4M Buy
651,624
+419,622
+181% +$8.27M 0.07% 240
2015
Q4 		$4.76M Buy
232,002
+195,985
+544% +$3.76M 0.02% 402
2015
Q3 		$616K Buy
36,017
+5,074
+16% +$92.7K ﹤0.01% 750
2015
Q2 		$576K Buy
+30,943
New +$574K ﹤0.01% 771

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Acadian Asset Management's VIVO Position: Q3 2021 in Review

Acadian Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 4,162 shares — an estimated $92K sold.

Acadian Asset Management first reported a position in VIVO in Q2 2015 and held it in 18 quarters. The position peaked at $13.6M in Q2 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

  • Acadian Asset Management reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 4,162 Meridian Bioscience Inc shares in Q3 2021, an estimated $92K.
  • Acadian Asset Management first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 18 quarters.
  • Acadian Asset Management's Meridian Bioscience Inc position peaked at $13.6M in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.